Check Your Eligibility

Answer a few questions to see if you may qualify for this trial.

Step 1 of 8

Are you positive for the HLA-A*02:01 genetic marker?

This is a genetic test that determines if you can receive this specific immunotherapy. If you are HLA-A*02:01 positive, you need to have tried tebentafusp first (unless your doctor determined it wasn't suitable for you). This is checked first because it may determine your eligibility before other tests.

Show original medical criteria

HLA-A*02:01 positivity is a biomarker requirement for this trial. If positive, you must have previously received tebentafusp treatment unless it was unavailable or clinically inappropriate.

This is informational only — not medical advice. Always discuss eligibility with your oncologist.